Amgen (AMGN) Tops Q4 EPS by 24c
Tweet
Share
E-mail_58cbc46cd3c33.jpg)
Get Alerts AMGN Hot Sheet
Price: $386.67 -1.18%
Revenue Growth %: +5.1%
Financial Fact:
Income before income taxes: 2.42B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +5.1%
Financial Fact:
Income before income taxes: 2.42B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Amgen (NASDAQ: AMGN) reported Q4 EPS of $4.36, $0.24 better than the analyst estimate of $4.12. Revenue for the quarter came in at $6.85 billion versus the consensus estimate of $6.88 billion.
For earnings history and earnings-related data on Amgen (AMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HSBC Downgrades Amgen (AMGN) to Hold
- AMGEN TO PRESENT AT THE MORGAN STANLEY 24TH ANNUAL GLOBAL HEALTHCARE CONFERENCE
- UBS Reiterates Neutral Rating on Yeti Holdings Inc. (YETI) Ahead of Analyst Meeting
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
